Deep Dives Nanobiotix’s Laurent Lévy: “We’re creating a new class of medicines and a potential $6bn blockbuster." , and Helen O'Reilly-Durand July 31, 2026
Deep Dives The Bicycle and The Helicopter: How HR Path Quietly Built a Billion-Dollar Empire , and Chris O'Brien July 24, 2026
Deep Dives Planity Hits €80M ARR: CEO Reveals the SaaS Moat That AI and Rivals Can't Copy , and Helen O'Reilly-Durand July 17, 2026
Deep Dives French Corporates Can No Longer Afford to Treat Startups as Experiments , and Helen O'Reilly-Durand July 10, 2026
Newsletter Essential Summer Reads #2: Nuclear Meltdown: How NAAREA Burned Through €90 Million and Collapsed in Spectacular Fashion , and Chris O'Brien , and Helen O'Reilly-Durand August 7, 2026
Newsletter Essential Summer Reads #1: How Juisci Is Using AI to Save Doctors 8 Hours a Week and Fight Medical Misinformation , and Chris O'Brien , and Helen O'Reilly-Durand August 5, 2026
Newsletter 🇫🇷 French Tech Wire: Nanobiotix’s $6 Billion Physics Bet , and Chris O'Brien , and Helen O'Reilly-Durand July 31, 2026
Deep Dives Nanobiotix’s Laurent Lévy: “We’re creating a new class of medicines and a potential $6bn blockbuster." , and Helen O'Reilly-Durand July 31, 2026